The ATS 2026 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert sessions addressing new developments and considerations in cellular and molecular biology, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the ATS365 platform. For more information on these and other sessions to be presented May 15–20 in Orlando, Fla., visit the online Advance Program.
- Respiratory Innovation Summit
- PG21 TRANSLATIONAL WINDOWS INTO THE LUNG MICROENVIRONMENT: ADVANCES WITH PRECISION-CUT LUNG SLICES
- A26 JOINT PEDIATRICS / CRITICAL CARE: PHYSIOLOGY, PHENOTYPES, AND TRAJECTORIES IN ACUTE RESPIRATORY FAILURE ACROSS THE LIFESPAN
- A18 THE AIR WE SHARE: POLLUTION, PULMONARY HEALTH, AND POLICY PERSPECTIVES
- A14 SEPSIS AND THE INJURED LUNG: DEFINING MECHANISMS AND IMPROVING PATIENT SURVIVAL
- A22 IMMUNOLOGICAL INSIGHTS IN ILD AND TRANSPLANT OUTCOMES
- A35 DECODING PARENCHYMAL LUNG DISEASE: INTERSTITIAL AND VASCULITIC INSIGHTS
- A33 FROM THE DARK SIDE TO THE LUNG SIDE: THE EPIC BATTLE AGAINST ARDS AND INFECTION
- A34 CHARTING THE UNSEEN TRAILS LEADING TO COPD
- A32 MAPPING THE ASTHMA LANDSCAPE: A DEEP DIVE INTO COMPREHENSIVE PHENOTYPING AND INHALED INNOVATIONS
- A80-2 FROM CELL CIRCUITS TO SCREENING STRATEGIES: UNCOVERING NOVEL MOLECULAR MECHANISMS AND ACCELERATING LUNG CANCER SCREENING IMPLEMENTATION
- A77 NEURO-RESPIRATORY INTERACTIONS: A CRITICAL CONNECTION
- A76 INTERROGATING NOVEL MECHANISMS IN CHRONIC AIRWAY DISEASE
- A73 NOVEL MOLECULAR DETERMINANTS OF COPD AND LUNG CANCER PATHOGENESIS
- A74 SENESCENCE, TISSUE MECHANICS, AND FIBRO-INFLAMMATORY CROSSTALK IN LUNG FIBROSIS
- A2 VISUALIZING THE TARGET: IMAGE-BASED MULTIMODAL PROFILING OF MICRO AND MACROENVIRONMENT IN LUNG DISEASE
- A8 THE WOUNDED LUNG: CELLULAR STRESS, INFLAMMATION AND CARCINOGENESIS
- A10 IS IT SARCOIDOSIS? – I DON’T KNOW
- A7 FROM EARLY DEVELOPMENT THROUGH AGING: SEX AND GENDER EFFECTS ON CARDIOPULMONARY DISEASE
- A4 HOST-DIRECTED THERAPEUTICS IN SEPSIS: LESSONS LEARNED AND FUTURE DIRECTIONS
- A6 THE OBESE LUNG MICROENVIRONMENT: NEW INSIGHTS INTO ASTHMA PATHWAYS AND THERAPEUTIC TARGETS
- Roadmap to Clean Air and Healthier Lungs
- MTE13 MICROPLASTICS: RESEARCH CHALLENGES, OPPORTUNITIES, AND APPROACHES
- MTE4 SMALL BUT MIGHTY-EVS IN LUNG HEALTH AND DISEASE
- MTE5 BRONCHIECTASIS: A SILENT STORM BEHIND THE COUGH
- MTE7 EXPLORING PUBLIC DATASETS AND INTEGRATING MULTI-OMICS FOR TRANSLATIONAL RESEARCH: AN INVESTIGATOR’S GUIDE TO NAVIGATING THE WORLD OF OMICS
- Towards a Global Framework for Lung Health – The Forum of International Respiratory Societies (FIRS) Lung Health Taskforce
- MD6 VHA LUNG PRECISION ONCOLOGY PROGRAM: KEY FINDINGS FROM SCREENING RESEARCH
- MD5 UPDATES ON ARDS, PNEUMONIA, AND SPESIS PHENOTYPING CONSORTIUM
- MD1 RED JOURNAL IN ACTION 1: EARLY CAREER LUNG RESEARCH HIGHLIGHTS
- MD8 NIH RECOVER AND C4R COHORTS: PULMONARY COMPLICATIONS AND IMMUNE DYSFUNCTION IN LONG-COVID ACROSS THE LIFESPAN
- MD3 THE COLLABORATION CATALYST: ACCELERATING CLINICAL IMPACT THROUGH ACADEMIC-INDUSTRY SYNERGY
- Counting Down Towards 2030: Heralding Better Prevention and Treatment Strategies for Eliminating Tuberculosis
- A104 JOINT CC / RCMB BENCH-TO-BEDSIDE: NOVEL INSIGHTS INFORMING CLINICAL TRANSLATION IN ACUTE LUNG INJURY
- A106 YOU’VE GOT A FRIEND IN ME: BASIC, GENETIC, AND OMICS RESEARCH TO ADVANCE CHILDREN’S RESPIRATORY HEALTH
- A109 FROM CELLS TO CIRCULATION: DETERMINANTS OF PULMONARY FIBROSIS SEVERITY AND PROGRESSION
- A110 CLOSING THE GAP: ADVANCES IN PULMONARY FIBROSIS
- A93 THE INTERSECTION OF IMMUNITY AND FIBROSIS: EXPOSURES AND MECHANISTIC OUTCOMES IN INTERSTITIAL LUNG DISEASE
- A84 PRISM, GOLD 0, AND PRE-COPD: USEFUL CONCEPTS OR DIAGNOSTIC OVERREACH?
- A86 ILLNESS & IDENTITY: SYSTEMIC OPPRESSION & THE ETHICS OF CARE
- A87 YOU BREATHE WHAT YOU EAT – EFFECTS OF NUTRITION ON LUNG HEALTH AND DISEASE
- Strengthening the Healthcare Workforce for Respiratory Care in the Global South: Lessons from the Paolo Chiesi Foundation supported initiatives
- Buenos Dias ATS Talk: Hot Topics in Pulmonary Vascular Disease: From Acute PE to Chronic Pulmonary Hypertension
- B29 THE LATEST IN AIRWAY SYMPTOMS AND DISEASE
- B28 MOLECULAR AND CELLULAR DETERMINANTS OF AIRWAY BIOLOGY AND LUNG IMMUNITY
- B17 BEST IN PEDIATRICS: BIBBIDI-BOBBIDI-BREATH!
- B21 DECODING THE LUNG CANCER ECOSYSTEM: MOLECULAR MECHANISMS, TUMOR MICROENVIRONMENT, AND TUMOR-HOST IMMUNITY
- B19 EMERGING THERAPEUTIC STRATEGIES FOR FIBROTIC LUNG DISEASE
- B34 FRONTIERS IN LUNG TRANSPLANT: EXPLORING IMMUNITY AND REJECTION
- B33 UNRAVELING THE OMIC LAYERS: TRANSLATIONAL INSIGHTS IN AIRWAYS DISEASE
- B32 RISE OF THE BIOLOGICS: A NEW HOPE FOR BREATHING EASIER
- B79 PULMONARY FIBROSIS: BENCH TO BEDSIDE
- B75 DETERMINANTS OF SEVERITY AND RESOLUTION IN ACUTE LUNG INJURY AND TRANSPLANT REJECTION
- B76 IMMUNE, VASCULAR AND OTHER NEW MECHANISMS IN THE BIOLOGY OF COPD
- B77 FROM TARGET DISCOVERY TO CLINICAL TRANSLATION IN PULMONARY FIBROSIS
- B58 ASSESSING LUNG HEALTH IN THE REAL WORLD
- B5 NOVEL INSIGHTS INTO THE COMPLEMENT INFLUENCE ON LUNG MICROENVIRONMENT IN ACUTE AND CHRONIC DISEASE
- B11 QUESTION EVERYTHING: RETHINKING CONVENTIONAL APPROACHES TO CAP
- The Changing Landscape of Drug-Resistant Tuberculosis: Latest Updates
- MD13 RED JOURNAL IN ACTION 2: LUNG REPAIR MODELS AND MECHANISMS
- MD23 INTERROGATING INTERACTIONS BETWEEN IMMUNITY, MECHANICS, AND ORGAN SYSTEMS IN PULMONARY FIBROSIS
- MD18 NEW RESULTS FROM THE SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD STUDY (SPIROMICS ) FAMILY OF STUDIES
- MD20 LEVERAGE HUMAN-BASED APPROACHES TO STUDY LUNG RESILIENCE AND DISEASE
- MD21 IMMUNE AND EPITHELIAL PREDICTORS OF ASTHMA RISK: LESSONS FROM EARLY LIFE COHORT STUDIES
- B109 CELLULAR, GENETIC, AND DEVELOPMENTAL DRIVERS OF COPD, EMPHYSEMA AND SARCOPENIA
- B111 TRANSLATIONAL ADVANCES IN THORACIC ONCOLOGY: INTEGRATING MECHANISTIC INSIGHTS, MOLECULAR BIOMARKERS, AND RADIOMIC DISCOVERIES
- B97 WHERE THERE’S HEAT, THERE’S (SOMETIMES) FIRE: RESPIRATORY CONSEQUENCES OF A WARMING WORLD
- B100 ALLOGRAFTS GONE WILD: CELLS, SIGNALS AND THE DRAMA OF LUNG TRANSPLANTATION
- B92 ESCALATING USE, EMERGING SCIENCE: VAPE/SMOKE INDUCED LUNG DISEASE
- B88 REWRITING THE CODE: PRECISION DELIVERY VECTORS AND GENE THERAPY FOR PULMONARY VASCULAR DISEASES
- B93 LIVING LANDSCAPES: HOW LUNG MICROENVIRONMENTS ORCHESTRATE HOST RESPONSE DURING LUNG INFECTIONS
- C29 SENESCENCE, METABOLISM, AND CELL FATE IN LUNG REPAIR AND FIBROSIS
- C21 FROM OREXIN AGONISTS TO OXYBUTYNIN: A NEW ERA OF PHARMACOLOGIC THERAPIES IN SLEEP MEDICINE
- C20 THE NEXT TOP MODEL: NOVEL LUNG MODELS FOR INVESTIGATING PULMONARY HEALTH AND DISEASE
- C19 HOW TO FIX A LUNG: TREATMENT, REPAIR AND REGENERATION AFTER LUNG INJURY
- C32 NAVIGATING IMMUNITY: A CLINICAL DIVE INTO ALLERGIC PHENOMENON AND IMMUNE DEFICIENCIES
- C33 FROM DATA TO BREATHS: STORIES OF ASTHMA UNFOLDED
- C34 ASTHMA UNVEILED: A THEMATIC JOURNEY FROM OMICS TO PRECISE CHARACTERIZATION OF PHENOTYPE AND THERAPIES
- C74 THE LUNG UNDER SIEGE: INFLAMMATION AND INFECTION
- C80 COMPLEX THORACIC ONCOLOGY CASES: DIAGNOSTIC AMBIGUITY, MULTIDISCIPLINARY DECISION-MAKING, AND THERAPEUTIC CHALLENGES
- C78 BEYOND CONVENTIONAL BRONCHOSCOPY: ADVANCED DIAGNOSTIC AND THERAPEUTIC TECHNIQUES IN THORACIC ONCOLOGY
- C70 FROM EXPOSURE TO THERAPY: TRANSLATIONAL BIOLOGY OF AIRWAY INFLAMMATION AND LUNG INFECTION
- C59 CASE REPORTS IN ENVIRONMENTAL AND OCCUPATIONAL HEALTH
- C2 IMMUNE ACTIVATION AND FIBROSIS WITHIN THE PULMONARY VASCULAR MICROENVIRONMENT
- MTE32 MODELING THE DISEASED LUNG MICROENVIRONMENT: EXPERIMENTAL STRATEGIES FOR COMPLEX CO-MORBID CONDITIONS
- MTE28 PERSONALIZED SLEEP HEALTH: A METABOLIC MEDICINE FRONTIER
- C105 PERSONALIZING RESPIRATORY SUPPORT IN ARF AND ARDS: MECHANISMS, MONITORING, AND MODELING
- C107 ADVENTURES IN ACUTE LUNG INJURY, REPAIR AND DEVELOPMENT
- C101 THE COPD RUBIX CUBE: ‘OMICS AND MECHANISMS
- C94 ONE LUNG, MANY OMICS: HOW ENVIRONMENTAL EXPOSURES SHAPE LUNG BIOLOGY
- C99 UNRAVELING AIRWAY BIOLOGY: NEW INSIGHTS INTO DISEASE
- C97 NOVEL APPROACHES AND UNDERSTANDING TO SKELETAL MUSCLE, REHABILITATION AND ACUTE RECOVERY
- C98 NEW INSIGHTS INTO COPD PATHOGENESIS
- C84 ENDOTHELIAL DYSFUNCTION IN CRITICAL ILLNESS: FROM MECHANISMS TO THERAPIES
- C82 LUNG FIBROSIS ACROSS THE LIFESPAN: EMERGING OPPORTUNITIES FOR INTERVENTION
- C86 VASCULOPATHIES IN PULMONARY DISEASE? THE DARK SIDE OF THE LUNG
- D29 NEXT-GENERATION ANTI-FIBROTIC THERAPIES: TARGETS, TECHNOLOGIES, AND TRANSLATION
- D15 BE OUR GUEST: EXPLORING CUTTING-EDGE BPD RESEARCH
- D19 THE NEXT GENERATION: NOVEL TARGETS AND THERAPIES FOR CHRONIC LUNG DISEASE
- D18 ENVIRONMENTAL AND CELLULAR STRESSORS SHAPING LUNG BIOLOGY, IMMUNITY AND DISEASE
- D21 TYPE 2 IMMUNITY AND BEYOND: ASTHMA MECHANISMS AND TARGETS
- D7 ENDOTHELIAL HETEROGENEITY IN THE LUNG MICROENVIRONMENT: AGE AND DISEASE PERSPECTIVES
- D8 THERAPEUTIC ACUTE INTERMITTENT HYPOXIA: TRANSLATION FROM ANIMAL MODELS TO HUMANS WITH INJURY OR DISEASE
- D2 A TALE OF TWO TRANSPLANTS: THE CONVERGENT PATHS OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION AND PULMONARY GRAFT VERSUS HOST DISEASE
- D108 EMERGING CONCEPTS IN THE PATHOGENESIS OF COPD AND LUNG CANCER
- D110 DIAGNOSTIC DILEMMAS AND RARE ENTITIES IN THORACIC ONCOLOGY: LESSONS FROM COMPLEX CASES
- D109 NOVEL INSIGHTS INTO PULMONARY VASCULAR DISEASES
- D96 STICKY SITUATIONS: MUCUS PLUGGING IN PULMONARY DISEASE
- D95 GOOD INTENTIONS, BAD OUTCOMES: HOW LUNGS BECOME FIBROTIC
- D101 INFLAMMATION AND RESILIENCE: HOST RESPONSES IN LUNG INJURY AND INFECTION
- D86 LOCATION, LOCATION, LOCATION: INTERCELLULAR COMMUNICATION DRIVING LUNG DISEASE
- D83 EARTH, WIND, AND FIRE: TRANSLATIONAL LESSONS FROM A CHANGING PULMONARY (MICRO)ENVIRONMENT
- D84 EAT. KILL. SURVIVE. THE MACROPHAGE-NTM STANDOFF
- MD29 COPD UNDERSTANDING COPD PROGRESSION AND HETEROGENEITY
Don’t Miss the ATS 2026 International Conference
Register today for the ATS 2026 International Conference to experience this year’s premier respiratory health conference, May 15-20 in Orlando. Join your colleagues to learn about the latest developments in pulmonary, critical care, and sleep medicine.
Not an ATS member? Join today and save on your conference registration!